oxazolidin-2-one has been researched along with Atypical Mycobacterial Infection, Disseminated in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (33.33) | 29.6817 |
2010's | 9 (37.50) | 24.3611 |
2020's | 7 (29.17) | 2.80 |
Authors | Studies |
---|---|
Chu, H; Fan, J; Guo, Q; Li, B; Tan, F; Wang, X; Xu, L; Zhang, Y; Zhang, Z | 1 |
He, W; Li, F; Ou, X; Shen, C; Wang, S; Wang, Y; Xia, H; Xiao, J; Zhao, Y; Zheng, H | 1 |
Aragaw, WW; Cangialosi, J; Dartois, V; Dick, T; Negatu, DA | 1 |
Hoefsloot, W; Koeken, VACM; Pennings, LJ; Ruth, MM; Svensson, EM; van Ingen, J; Wertheim, HFL | 1 |
Hariu, M; Imai, H; Kabutoya, Y; Kamioka, Y; Seki, M; Shoji, M; Takano, K; Watanabe, Y | 1 |
Ding, X; Jiang, Y; Sun, B; Tong, A; Wu, Y; Zhao, Y | 1 |
Jhun, BW; Kim, DH; Kim, SY; Koh, WJ | 1 |
Cho, YL; Choe, JH; Jang, J; Jeong, J; Jo, EK; Kim, G; Kim, TS; Kim, YJ; Kwon, HJ; Park, DE; Yang, CS | 1 |
Arthur, M; Compain, F; Dorchène, D; Dubée, V; Gaillard, JL; Herrmann, JL; Heym, B; Soroka, D | 1 |
Arthur, M; Le Run, E; Mainardi, JL | 1 |
Gui, J; Hong, CY; Li, JL; Liang, J; Wang, F | 1 |
Anunnatsiri, S; Chetchotisakd, P | 1 |
Bertó, J; Del Pozo, JL; Leiva, J; Yuste, JR | 1 |
Lin, YH; Liu, TC | 1 |
Borole, AJ; Chilgar, RM; D'Silva, JA; Thomas, M | 1 |
Díaz-Llopis, M; Dolz-Marco, R; Gallego-Pinazo, R; Millán, JM; Udaondo, P | 1 |
López, M; Rodriguez Díaz, JC; Royo, G; Ruiz, M | 1 |
Kyle, SD; Porter, WM | 1 |
Chauffour, A; Jarlier, V; Ji, B; Lefrançois, S; Robert, J; Truffot, C | 1 |
Falagas, ME; Ntziora, F | 1 |
Fierlbeck, G; Hoetzenecker, W; Kempf, VA; Klingel, K; Metzler, G; Schanz, S; Ulmer, A | 1 |
Akinci, P; Cavusoglu, C; Soyler, I | 1 |
Blinkhorn, R; Brown-Elliott, BA; Crist, CJ; Mann, LB; Wallace, RJ | 1 |
Bråbäck, M; Forsgren, A; Riesbeck, K | 1 |
1 review(s) available for oxazolidin-2-one and Atypical Mycobacterial Infection, Disseminated
Article | Year |
---|---|
Linezolid for the treatment of patients with [corrected] mycobacterial infections [corrected] a systematic review.
Topics: Acetamides; Adolescent; Adult; Anemia; Anti-Infective Agents; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Linezolid; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Optic Nerve Diseases; Oxazolidinones; Peripheral Nervous System Diseases; Treatment Outcome; Tuberculosis | 2007 |
23 other study(ies) available for oxazolidin-2-one and Atypical Mycobacterial Infection, Disseminated
Article | Year |
---|---|
A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity
Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Pyridones | 2021 |
Topics: Anti-Bacterial Agents; China; Humans; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Oxazolidinones | 2023 |
Side-by-Side Profiling of Oxazolidinones to Estimate the Therapeutic Window against Mycobacterial Infections.
Topics: Anti-Bacterial Agents; Humans; Linezolid; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Oxazolidinones; Tuberculosis | 2023 |
Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Leprostatic Agents; Macrolides; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Oxazolidinones; Tetrazoles | 2020 |
Mycobacterium abscessus Associated Peritonitis with CAPD Successfully Treated Using a Linezolid and Tedizolid Containing Regimen Suggested Immunomodulatory Effects.
Topics: Adult; Anti-Bacterial Agents; Chronic Disease; Female; Glomerulonephritis; Humans; Immunocompromised Host; Linezolid; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Tetrazoles | 2020 |
Evaluation of the Anti-Mycobacterial Activity of Newly Synthesized (S)-N-(3-(2-Fluoro-4'-(2-Amino-4-Thiazolyl)Biphenyl-4-Yl)-2-Oxo-1,3-Oxazolidie-5-Ylmethyl) Acetamide Derivative in Vitro and in Mycobacterium marinum-Infected Zebrafish.
Topics: Acetamides; Animals; Anti-Bacterial Agents; China; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Oxazolidinones; Zebrafish | 2021 |
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Macrolides; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Oxazolidinones | 2021 |
Activity of LCB01-0371, a Novel Oxazolidinone, against Mycobacterium abscessus.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Linezolid; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Oxazolidinones | 2017 |
In vitro activity of tedizolid against the Mycobacterium abscessus complex.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Tetrazoles; Tigecycline | 2018 |
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Macrophages; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Rifabutin; Tetrazoles | 2019 |
[Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Topics: Acetamides; Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Culture Media; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Oxazolidinones; Sensitivity and Specificity; Tobramycin | 2013 |
Linezolid in the treatment of disseminated nontuberculous mycobacterial infection in anti-interferon-gamma autoantibody-positive patients.
Topics: Acetamides; Adolescent; Adult; Anti-Bacterial Agents; Autoantibodies; Drug Administration Schedule; Female; Hospitals, University; Humans; Interferon-gamma; Linezolid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Retrospective Studies; Thailand | 2014 |
Prolonged use of tedizolid in a pulmonary non-tuberculous mycobacterial infection after linezolid-induced toxicity.
Topics: Aged; Anti-Bacterial Agents; Drug Tolerance; Humans; Linezolid; Lung; Male; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Nontuberculous Mycobacteria; Oxazolidinones; Tetrazoles; Time Factors | 2017 |
Mycobacterium chelonae infection involving the auricle.
Topics: Acetamides; Adult; Anti-Infective Agents; Clarithromycin; Ear Auricle; Humans; Linezolid; Lymph Nodes; Lymphadenitis; Male; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Neck; Oxazolidinones; Skin Diseases, Bacterial; Treatment Outcome | 2012 |
Periprosthetic atypical mycobacterial infection in breast implants: a new kid on the block!
Topics: Acetamides; Adult; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Breast Implants; Clarithromycin; Female; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Mammaplasty; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Reoperation | 2013 |
Topical linezolid for refractory bilateral Mycobacterium chelonae post-laser-assisted in situ keratomileusis keratitis.
Topics: Acetamides; Adult; Anti-Infective Agents; Cornea; Drug Resistance, Bacterial; Eye Infections, Bacterial; Follow-Up Studies; Humans; Keratitis; Keratomileusis, Laser In Situ; Linezolid; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Myopia; Oxazolidinones; RNA, Ribosomal, 23S; Surgical Wound Infection | 2012 |
In vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Oxazolidinones; Quinolines; Spain | 2003 |
Mycobacterium chelonae infection successfully treated with oral clarithromycin and linezolid.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Forearm; Humans; Linezolid; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Opportunistic Infections; Oxazolidinones; Skin Diseases, Bacterial | 2004 |
In vitro and in vivo activities of rifampin, streptomycin, amikacin, moxifloxacin, R207910, linezolid, and PA-824 against Mycobacterium ulcerans.
Topics: Acetamides; Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Colony Count, Microbial; Diarylquinolines; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Foot; In Vitro Techniques; Linezolid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Nitroimidazoles; Oxazolidinones; Quinolines; Rifampin; Streptomycin; Survival Analysis; Time Factors | 2006 |
Dissemination of a localized cutaneous infection with Mycobacterium chelonae under immunosuppressive treatment.
Topics: Acetamides; Anti-Infective Agents; Clarithromycin; Diagnosis, Differential; Female; Humans; Immunocompromised Host; Linezolid; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Skin Ulcer | 2007 |
Activities of Linezolid against nontuberculous mycobacteria.
Topics: Acetamides; Anti-Infective Agents; Endpoint Determination; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Oxazolidinones; Species Specificity; Turkey | 2007 |
Successful treatment of disseminated Mycobacterium chelonae infection with linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Humans; Linezolid; Male; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Treatment Outcome | 2001 |
Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (Synercid) compared to its susceptibilities to reference macrolides and quinolones.
Topics: Acetamides; Anti-Bacterial Agents; Fluoroquinolones; Humans; Ketolides; Linezolid; Macrolides; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Oxazolidinones; Virginiamycin | 2002 |